Understanding the role of phenotypic switching in cancer drug resistance
From MaRDI portal
Publication:2297830
DOI10.1016/j.jtbi.2020.110162zbMath1430.92036arXiv2001.07690OpenAlexW2999859696WikidataQ92738098 ScholiaQ92738098MaRDI QIDQ2297830
Subhajyoti De, Einar Bjarki Gunnarsson, Kevin Leder, Jasmine Foo
Publication date: 20 February 2020
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/2001.07690
Problems related to evolution (92D15) Medical applications (general) (92C50) Genetics and epigenetics (92D10)
Related Items (4)
A continuation technique for maximum likelihood estimators in biological models ⋮ Statistical inference of the rates of cell proliferation and phenotypic switching in cancer ⋮ Cell population growth kinetics in the presence of stochastic heterogeneity of cell phenotype ⋮ Transition therapy: tackling the ecology of tumor phenotypic plasticity
Cites Work
This page was built for publication: Understanding the role of phenotypic switching in cancer drug resistance